RAAQ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
RAAQ is not a good buy right now for an impatient investor. Despite bullish moving averages, momentum is fading (MACD contracting), price is sitting below the pivot (10.4) and right on support (S1 ~10.335), and there are no near-term catalysts (no recent news, no notable institutional/insider trend). With the next-month pattern-based outlook skewing negative (-4.36%), the risk/reward is not attractive for an immediate entry.
Trend/structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) suggests an uptrend bias, but current price (10.33) is below the pivot (10.4) and essentially sitting on first support (S1 10.335), which weakens immediate bullish confirmation. Momentum: MACD histogram is positive (0.00603) but contracting, implying upside momentum is fading rather than accelerating. RSI: RSI_6 = 44.18 (neutral-to-slightly weak), not signaling an oversold bounce. Levels: Support S1 10.335 and S2 10.295; Resistance R1 10.465 and R2 10.505. A clean reclaim of 10.40–10.47 would improve the long setup; losing 10.295 increases downside risk. Pattern-based forecast: 40% chance to -0.54% next day, +1.88% next week, -4.36% next month—near-term mixed but skewing weaker over a month.
Intellectia Proprietary Trading Signals
supports a longer-term upward bias.
Momentum is weakening: MACD positive but contracting; RSI below 50 suggests demand is not strong.
Price is below pivot (10.4), implying the market is not currently confirming upside continuation.
No news in the past week—lack of catalysts reduces odds of an urgent upside move.
Trading trends: hedge funds neutral; insiders neutral—no strong participation signals.
Pattern-based outlook points to a negative next-month expectation (-4.36%).
Latest quarter: 2025/Q3. Reported revenue is 0 (no operating revenue). Net income 1,685,701 and EPS 0.07 appear driven by non-operating factors rather than business growth. With revenue at zero and no stated YoY growth, the quarter does not show operating expansion or a clear growth trajectory.
No analyst rating or price target data was provided, so there is no observable recent trend in Wall Street upgrades/downgrades or target changes. Without published coverage/targets here, the pro/con view from analysts cannot be assessed from the dataset.
